An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly
NCT07583563
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Acromegaly
Interventions
DRUG:
Octreotide subcutaneous depot
Sponsor
Camurus AB